Pure Global AI
Registration holder profile

GLOBO REAGENTES E EQUIPAMENTOS P/ LABORATORIOS LTDA

Brazil69 ANVISA registrations50 unique technical categoriesSep 24, 2020 – Aug 17, 2026
Verified
69
Total products
50
Technical names
Sep 2020
Earliest registration
Aug 2026
Latest registration
Regulatory footprint
Search GLOBO REAGENTES E EQUIPAMENTOS P/ LABORATORIOS LTDA across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this holder
AUTOTESTE PARA GONADOTROFINA CORIÔNICA HUMANA (HCG)
Família Teste de Gravidez
Class II · Aug 17, 2026
25 HYDROXYVITAMIN D3 OF VITAMIN D
ULTRA VITAMINA D
Class II · Aug 10, 2026
APOLIPOPROTEIN B
iProtin ApoB
Class II · May 18, 2026
Instrument for analysis of general biochemistry, hormones, drugs or proteins
iProtin Reader
Class II · May 18, 2026
C-REACTIVE PROTEIN
iProtin CRP
Class II · May 18, 2026
Most popular products
Products with most registrations
Instrument for analysis of general biochemistry, hormones, drugs or proteins
5 registrations
COMBINED PARAMETERS - RESPIRATORY PANEL
3 registrations
HEMOGLOBIN
3 registrations
25 HYDROXYVITAMIN D3 OF VITAMIN D
2 registrations
C-REACTIVE PROTEIN
2 registrations
Top manufacturers
Manufacturers with the most products registered by this holder
XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
18 products
TAIDOC TECHNOLOGY CORPORATION
15 products
TASCOM CO., LTD
13 products
SD BIOSENSOR HEALTHCARE PVT. LTD
8 products
HANGZHOU BIOTEST BIOTECH CO., LTD
4 products
Products per risk level
Distribution of distinct commercial products by ANVISA risk classification
Class II53Distinct Products · 53 total registrations
Class III10Distinct Products · 10 total registrations
Class IV6Distinct Products · 6 total registrations
About this profile

Access comprehensive registration holder profile for GLOBO REAGENTES E EQUIPAMENTOS P/ LABORATORIOS LTDA through Pure Global AI's free Brazil medical device database. This registration holder manages 69 medical device registrations with ANVISA across 50 unique technical categories. Their regulatory portfolio spans from Sep 24, 2020 to Aug 17, 2026.

This page provides comprehensive insights including 5 recent product registrations, 5 most popular products led by Instrument for analysis of general biochemistry, hormones, drugs or proteins with 5 registrations, partnerships with 5 key manufacturers including XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD. and TAIDOC TECHNOLOGY CORPORATION, and products across 3 risk classifications with 53 Class II devices. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping distributors understand market dynamics and identify business opportunities.